Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by Yajneon Dec 14, 2021 2:48am
451 Views
Post# 34227790

This is the part

This is the part...of blog letter that caught my attention. The VMS+ has now been integrated into the GEHC EchoPak analytic platform. IMHO the GE roll-out is likely coming in Q1 in the new year when they split GE as per previously announced. The new leadership of GEHC will be eager to make a splash and VMS+ will be part of the splash. Of course imiprovements will continue, as they always do. But IMO I expect the GE launch to happen in Q1, and yes, that means the future is approaching fast! JMHO DYODD!

After decades of OEMS improving 2D and 3D ultrasound machines and Ventripoint improving the analytics, it is now time to put it all together. It will not be long. We have already integrated the VMS+ into the GEHC EchoPak™ analytic platform. Automation is next. The future is approaching fast!
<< Previous
Bullboard Posts
Next >>